Retrospective, Observational Study in Patients Receiving a Dexamethasone Intravitreal Implant 0.7 mg for Macular Oedema Secondary to Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|233|1|18-26

ISSN： 0030-3755

Source： Ophthalmologica, Vol.233, Iss.1, 2014-12, pp. : 18-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg

By  

Case Reports in Ophthalmology, Vol. 3, Iss. 1, 2012-01 ,pp. : 30-34

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 207-215

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

Prospective Pilot Study: Efficacy of Intravitreal Dexamethasone and Bevacizumab Injections in the Treatment of Macular Oedema Associated with Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 43-49

Karger

Access to resources Recommend Favorite